Supplemental material for “Salicylate suppresses monocyte chemoattractant protein-1 production by targeting phosphodiesterase 3B inhibition in TNF-α-stimulated adipocytes”
Our study provides compelling evidence for a hitherto unknown anti-inflammatory pathway of salicylate in obesity-related inflammation and a rationale for the application of the prodrug of salicylate in metabolic diseases. The raw data for each result is provided here for research reference.
Steps to reproduce
ELISA，RT-qPCR，western blot， SPR， gene silencing，and other technologies were used in this study.